Liver dysfunction due to apoptosis in a patient with systemic lupus erythematosus

Lupus

Volumn 9, Issue 1, 2000, Pages 74-77

  Mukai, Masaya ^a   Bohgaki, Toshiyuki ^c   Notoya, Atsushi ^c   Kohno, Michifumi ^c   Tateno, Masatoshi ^a   Kobayashi, Seiichi ^b  

^a SAPPORO CITY GENERAL HOSPITAL   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NONE

Author keywords

Apoptosis; Lupus hepatitis; Programmed cell death; Soluble Fas ligand; Systemic lupus erythematosus

Indexed keywords

FAS LIGAND; PREDNISOLONE; STEROID;

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; CELL DEATH; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER DISEASE; LIVER FUNCTION; NICK END LABELING; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034063071     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120330000900115     Document Type: Article

References (11)

1. Hayashi N, Mita E. Fas system and apoptosis in viral hepatitis. J Gastroenterol Hepatol 1997; 12 (Suppl.): S223-S226.
2. Seino K, Kayagaki N, Takeda K et al. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 1997; 113: 1315-1322.
3. Gong WR, Pecci A, Roth S et al. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology 1998; 28: 492-502.
4. Feldmann G, Lamboley C, Moreau A, Bringuier A. Fas-mediated apoptosis of hepatic cells. Biomed Pharmacother 1998; 52: 378-385.
5. Shiota G, Oyama K, Noguchi N et al. Clinical significance of serum soluble Fas ligand in patients with acute self-limited and fulminant hepatitis. Res Comm Mol Pathol Pharmacol 1998; 101: 3-12.
6. Kovacs B, Liossis SNC, Dennis GJ, Tsokos GC. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus. Autoimmunity 1997; 25: 213-221.
7. McNally J, Yoo DH, Drappa J et al. Fas ligand expression and function in systemic lupus erythematosus. J Immunol 1997; 159: 4268-4636.
8. Atsumi T, Sagawa A, Jodo S et al. Severe hepatic involvement without inflammatory changes in systemic lupus erythematosus: report of two cases and review of literature. Lupus 1995; 4: 225-228.
9. Ksontini R, Colaviovanni DB, Josephs MD et al. Disparate roles for TNF-α and Fas ligand in concanavalin A-induced hepatitis. J Immunol 1998; 160: 4082-4089.
10. Jodo S, Kobayashi S, Kayagaki N et al. Serum level of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases. Clin Exp Immunol 1997; 107: 89-95.
11. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest 1990; 86: 69-74.